STS 2025

January 24 - 26
Visit us at Booth #414 to Discover
Artivion’s EDGE

Jump to a section to learn more:

Lunch Symposium

The Next Generation of ATAD Repair:
AMDSTM Hybrid Prosthesis Worldwide Experience and
Update on PERSEVERE IDE Study

Saturday, January 25th

11:55 AM – 12:55 PM

Room #150


Add event to calendar

AppleGoogleOffice 365OutlookOutlook.comYahoo

Moderator

Dr. Wilson Szeto

University of Pennsylvania, USA

Dr. William Brinkman

Introduction to AMDS and Results from the PERSEVERE US IDE Study

Baylor Scott and White Health, USA

Prof. Joerg Kempfert

History of AMDS: How it Works and World-wide Experience

German Heart Center Berlin, Germany

Dr. Fernando Fleischman

Best Practices for Success: Patient Selection and Implantation Techniques

University of Southern California, USA

AMDS

NOW COMMERCIALLY AVAILABLE IN USA UNDER FDA HDE

Learn More

Booth Talks

Visit us at Booth 414 to learn about the compelling clinical evidence behind our solutions


Optimizing Mitral Valve Replacement for Patients With Longer Life Expectancy

Friday, January 24th
9:15 AM - 9:30 AM

Add event to calendar

AppleGoogleOffice 365OutlookOutlook.comYahoo

Marc Ruel, MD, MPH, FAHA, FRCSC

Division Head and Minimally Invasive Cardiac Surgery Chair, Division of Cardiac Surgery
University of Ottawa Heart Institute, Canada

Endovascular Ascending Arch Repair with NEXUS Arch Stent Graft: Initial Investigational Experience

Friday, January 24th
4:00 PM - 4:15 PM

Add event to calendar

AppleGoogleOffice 365OutlookOutlook.comYahoo

Kyle Eudailey, MD

Medical Director, Division of Cardiothoracic Surgery
University of Alabama at Birmingham, USA

AMDS: A Novel Approach to Acute DeBakey
Type I Aortic Dissection Management

Saturday, January 25th
9:45 AM - 10:00 AM

Add event to calendar

AppleGoogleOffice 365OutlookOutlook.comYahoo

Fernando Fleischman, MD

Director of the Aortic Center
University of Southern California, USA

5-Year Outcomes in the Real-World: The
On-X® Aortic Valve with Low-Dose Warfarin

Saturday, January 25th
3:00 PM - 3:15 PM

Add event to calendar

AppleGoogleOffice 365OutlookOutlook.comYahoo

Marc Gerdisch, MD, FACS, FACC

Chief of Cardiovascular and Thoracic Surgery
Franciscan Health Heart Center, USA

Podium Presentations

Late-Breaker Presentation:


One-Year Results of a Novel Aortic Arch Hybrid Prosthesis for Open Repair of Acute DeBakey Type I Dissection with Malperfusion in the PERSEVERE Study

Friday, January 24th
10:00 AM - 10:15 AM

Add event to calendar

AppleGoogleOffice 365OutlookOutlook.comYahoo

Wilson Szeto, MD

Chief, Division of Cardiovascular Surgery
University of Pennsylvania Medicine, USA

Key Sessions of Interest:


Session Title: Arch Disease: Be Bold?
Topic: Open Arch Bare Metal Stenting in Type A Aortic Dissections

Thursday, January 23rd
3:15 - 3:22 PM

Wilson Szeto, MD

Chief, Division of Cardiovascular Surgery
University of Pennsylvania Medicine, USA

Session Title: Lifetime Strategy for Thoracic Aortic Disease
Topic: How I Do It: Open Arch Bare Stenting in ATAAD

Friday, January 24th
10:23 - 10:31 AM

Wilson Szeto, MD

Chief, Division of Cardiovascular Surgery
University of Pennsylvania Medicine, USA

Poster Presentations:


Mechanical vs Biological Valves for Modified Bentall Procedure; 10-Year Outcomes from a High-Volume Aortic Center

Giacomo Murana, MD, PHD

Cardiac Surgery Department
IRCCS-Azienda Ospedaliero
Universitaria di Bologna, Italy

The North American Ross
Consortium: 30-Day Retrospective
Outcomes

John B. Eisenga, MD

General Surgery Resident
Baylor University Medical Center, USA

The industry symposium and booth talks will be held in conjunction with the STS Annual Meeting. It is not part of the official STS scientific program. Continuing Medical Education (CME) credit for this activity is not offered by STS.

AMDS is RX Only: Humanitarian Use Device. Authorized by Federal Law for use in the treatment of Acute DeBakey Type I Aortic Dissection. The effectiveness of this device for this use has not been demonstrated. NEXUS is an investigative device limited by Federal (or United States) law to Investigation use only within the United States. All products and Indications are not available / approved in all markets.